SecBot SecBot

BFRGW

BullFrog AI Holdings, Inc.
Nasdaq· Pharmaceutical Preparations· Inc. NV· CIK 0001829247 Biotech & Drug Discovery
Warrants of BullFrog AI Holdings, Inc. · BFRG stock page →
—
Market cap
$1.7M
Nano cap
1 year
−65.4%
from $1.39 · Oct 27
30 days
−26.8%
from $0.6570
52-week range
$0.4290–1.68
−71% from high · low Sep 16
Avg volume 20D
3.48M
Oct 6 spike 37.77M
Short interest
🔒 Subscribers only
New fund stakes
0
Q2 2026 13F · 0 exits
Filing reports
5
analyzed by SecBot
SecBot read BEARISH 5 reports · latest
Balance 2 bearish · 1 bullish · 2 neutral oldest → newest, height = score
Avg score ·High conf. 4/5
Strongest BEARISH BullFrog AI Holdings filed an S-1 registration statement to register up to 2,000,000 additional shares of…
All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

Signal stack

Where each data set points today.

  • InstitutionsMIXED

    Q2 2026: 0 added (0 new), 1 trimmed or exited.

  • TrendDOWNTREND

    14% below its 50-day average.

Who's buying

13F· Q2 2026
0
new positions
0
exits
FundMoveSharesValue
UBS Group AGTRIM1,009$121.00
UBS Group AGTRIM1,789$531.00
Clear Street Group Inc.TRIM109,452$20.9K
UBS Group AGNEAR_EXIT3,060$584.00
UBS Group AGTRIM19,180$11.0K
UBS Group AGDOUBLED28,928$17.9K

Quarterly 13F filings are due 45 days after each quarter ends.

Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent
Oct 6, 2026
Press release
BullFrog AI Announces Positive Progress in Drug Discovery Program for Top 5 Global Pharmaceutical in Major Depressive Disorder
Achieves key commercial project milestones utilizing its proprietary artificial intelligence (“AI”) and machine learning platform to identify and…
Sep 8, 2026
Press release
BullFrog AI to Participate in September 2026 Investor Conferences
GAITHERSBURG, Md., Sept. 08, 2026 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), an AI…
Apr 22, 2026
Press release
BullFrog AI Regains Compliance with Nasdaq Shareholders’ Equity Requirement
Strengthened balance sheet provides capital runway into late 2027 Strengthened balance sheet provides capital runway into late 2027
Apr 14, 2026
Company news
BullFrog AI Announces Participation at AACR Annual Meeting
BullFrog AI team will be available to discuss its end-to-end drug discovery and development workflow at booth 2957 BullFrog AI team will be…
Apr 13, 2026
Activist
BullFrog AI Provides Business Update: Strengthened Balance Sheet Supports Continued Execution as Company Aims to Ramp Commercial Activity with Global Pharmaceutical and Biotechnology Partners
First commercial agreement with a top 5 global pharmaceutical company anchors a growing pipeline of enterprise discussions; runway secured into late…

Earnings setup

Estimates
PeriodEPS est.Range30D rev.Revenue
Current Q———$215.0K
Next Q———$350.0K
Current FY———$780.0K
Next FY———$5.3M

Short side

FINRA· Oct 15, 2026
🔒 Subscribers only
shares short
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Oct 6, 2026 Other
BullFrog AI Announces Positive Progress in Drug Discovery Program for Top 5 Global Pharmaceutical in Major Depressive Disorder
Achieves key commercial project milestones utilizing its proprietary artificial intelligence (“AI”)
Jun 30, 2026 Inst.
UBS Group AG — TRIM
1,009 shares ($121.00)
May 29, 2026 SEC
BullFrog AI Holdings filed an S-1 registration statement to register up to 2,000,000 additional shares of common stock…
S-1 — Impact 5/10
May 1, 2026 SEC
BullFrog AI Holdings, Inc. filed a DEFA14A (definitive additional proxy soliciting materials) on May 1, 2026. The…
DEFA14A — Impact 2/10
Apr 22, 2026 SEC
BullFrog AI Holdings, Inc. announced it has regained compliance with Nasdaq's minimum stockholders' equity requirement…
8-K — Impact 5/10
Mar 31, 2026 Inst.
UBS Group AG — TRIM
1,789 shares ($531.00)

SecBot reports

5 filings · 1 bullish · 2 bearish · 2 neutral
All BFRGW filing & press-release reports (5)